Clinical Trials › NCT06170970
RecruitingPhase 2
Solriamfetol for the Treatment of Multiple Sclerosis Fatigue
Sponsored by Johns Hopkins University
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 46
Target enrollment
1
U.S. states
Jun 2024
Start date
Mar 2027
Expected completion
Interventions / Treatments
SolriamfetolPlacebo
Conditions studied
Multiple SclerosisMultiple Sclerosis Fatigue
Where this trial is running (1 site)
Maryland1 site
Baltimore
Participating MS centers on MS Buddy (1)
Johns Hopkins Multiple Sclerosis Center
Baltimore, MD
Baltimore, MD
MS centers in Maryland
Compare treatment centers near a trial site by center type, providers and trials.
View Maryland centersMore Phase 2 trials
Browse all Phase 2 MS trialsThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.